Prebiotics, Probiotics, and Dietary Fiber in Gastrointestinal Disease

Gastroenterology Clinics of North America

Volumn 36, Issue 1, 2007, Pages 47-63

  Park, Jacqueline ^a   Floch, Martin H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BALSALAZIDE; CIPROFLOXACIN; LACTULOSE; MESALAZINE; METRONIDAZOLE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID;

BURKITT LYMPHOMA; CANCER RISK; CANCER SIZE; CLINICAL FEATURE; CLINICAL TRIAL; COLON RESECTION; COLON TUMOR; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CROHN DISEASE; DIARRHEA; DIETARY FIBER; DISEASE ASSOCIATION; DISEASE SEVERITY; DIVERTICULOSIS; DOSE RESPONSE; DRUG EFFICACY; ENTERITIS; FOOD INTAKE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SURGERY; HEPATIC ENCEPHALOPATHY; HIGH FIBER DIET; HUMAN; ILEITIS; INTESTINE FLORA; IRRITABLE COLON; NONHUMAN; PREVALENCE; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW; STAPHYLOCOCCUS INFECTION; ULCERATIVE COLITIS;

ANIMALS; DIETARY FIBER; GASTROINTESTINAL DISEASES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; PROBIOTICS; SACCHAROMYCES;

EID: 34247499102     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2007.03.001     Document Type: Review

References (108)

1. Luckey T.D. Introduction to intestinal microecology. Am J Clin Nutr 25 (1992) 1292-1294
2. Vonk R.J. Manipulation of colonic flora as ecosystem and metabolic organ: consequences for the organism. Scand J Gastroenterol 32 222 (1997) 1-114
3. Hart A.L., Stagg A.J., Graffner H., et al. Gut ecology (2002), Martin Dunitz Ltd, London
4. Floch M.H., and Moussa K. Probiotics and dietary fiber. The clinical coming of age of intestinal microecology. J Clin Gastroenterol 27 (1998) 99-100
5. Floch M.H. Soluble dietary fiber and short-chain fatty acids: an advance in understanding the human bacterial flora. Am J Gastroenterol 85 (1990) 1074-1076
6. Gibson G.R., and Roberfroid M.B. Dietary modulation of the human colonic microbiotia: introducing the concept of prebiotics. J Nutr 125 (1995) 1401-1412
7. Cummings J.H., Macfarlane G.T., and Englyst H.N. Prebiotic digestion and fermentation. Am J Clin Nutr 73 Suppl (2001) 4155-4205
8. Floch M.H. Prebiotics, probiotics and dietary fiber. In: Buchman A.L. (Ed). Clinical nutrition in gastrointestinal disease (2006), Slack, Thorofare (NJ)
9. Crittenden R.G. Prebiotics. In: Tannock G.W. (Ed). Probiotics: a critical review (1999), Horizon Scientific Press, Wymondham (UK) 141-156
10. Rastall R.A., and Gibson G.R. Prebiotic oligosaccharides: evaluation of biological activities and potential future developments. In: Tannock G.W. (Ed). Probiotics and Prebiotics: where are we going? (2002), Calister Academic Press, Norfolk (UK) 107-148
11. Fuller R. Probiotics in man and animals. J Appl Bacteriol 66 (1989) 365-378
12. Metchnikoff E. The prolongation of life: optimistic studies (1907), Butterworth-Heinemann, London
13. Kipeloff N. Lactobacillus acidophilus (1926), Williams & Wilkins, Baltimore (MD)
14. Rettger L.F., Levy M.N., Weinstein L., et al. Lactobacillus acidophilus and its therapeutic application (1935), Yale University Press, London
15. Montrose D., and Floch M.H. Probiotics used in human studies. J Clin Gastroenterol 39 (2005) 469-480
16. Floch M.H., and Montrose D.C. Use of probiotics in humans: an analysis of the literature. Gastroenterol Clin North Am 34 (2005) 547-570
17. Cleave T.L. The saccharine disease (1975), Keats Publishing, Inc., New Canaan (CT)
18. Burkitt D.P., and Trowell H.C. Refined carbohydrate foods and disease: some implications of dietary fiber (1975), Academic Press, London
19. Burkitt D.P., Walker A.R.P., and Painter N.S. Dietary fiber and disease. JAMA 229 (1974) 1068-1074
20. Asp N.-G.L. Classification and methodology of food carbohydrates is related to nutritional effects. Am J Clin Nutr 61 Suppl (1995) 930S-937S
21. Cummings J.H., and Englyst H.N. Gastrointestinal effects of food carbohydrate. Am J Clin Nutr 61 Suppl (1995) 938S-945S
22. Burkitt D.P. Related disease-related cause?. Lancet 2 (1969) 1229-1231
23. Larsson S.C., Giovannucci E., Bergkvist L., et al. Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer 92 9 (2005) 1803-1807
24. Peters U., Sinha R., Chatterjee N., et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361 9368 (2003) 1491-1495
25. Bingham S.A., Day N.E., Luben R., et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361 9368 (2003) 1496-1501
26. Fuchs C.S., Giovannucci E.L., Colditz G.A., et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 340 3 (1999) 169-176
27. Thun M.F., Calle E.E., Namboodiri M.M., et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst 84 19 (1992) 1491-1500
28. Park Y., Hunter D.J., Spiegelman D., et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 294 22 (2005) 2849-2857
29. MacLennan R., Macrae F., Bain C., et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas: the Australian polyp prevention project. J Natl Cancer Inst 87 (1995) 1760-1766
30. McKeown-Eyssen G.E., Bright-See E., Bruce W.R., et al. A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps: Toronto Polyp Prevention Group. J Clin Epidemiol 47 (1994) 525-536
31. Schatzkin A., Lanza E., Corle D., et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342 (2000) 1149-1155
32. Alberts D.S., Martinez M.E., Roe D.J., et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 342 (2000) 1156-1161
33. Asano T., and McLeod R.S. Dietary fibre for the prevention of colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2 (2002) CD003430
34. Beresford S.A., Johnson K.C., Ritenbaugh C., et al. Low-fat dietary pattern and risk of colorectal cancer: the women's health initiative randomized controlled dietary modification trial. JAMA 295 6 (2006) 643-654
35. Almy T.P., and Howell D.A. Diverticular disease of the colon. N Engl J Med 302 (1980) 324-330
36. Trowell H., Burkitt D.P., and Heaton K. Dietary fibre, fibre-depleted foods and disease (1985), Academic Press, London
37. Painter N.S. The cause of diverticular disease of the colon, its symptoms and complications: review and hypothesis. J R Coll Surg Edinb 30 (1985) 118-126
38. Hughes L.E. Postmortem survey of diverticular disease of the colon. Gut 10 (1969) 336-351
39. Painter N.S., Trowell H., Burkitt D.P., et al. Diverticular disease of the colon. In: Trowell H., Burkitt D., and Heaton D. (Eds). Dietary fibre, fibre-depleted foods and disease (1985), Academic Press, London 145-160
40. Aldoori W.H., Giovannucci E.L., Rimm E.B., et al. A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr 60 (1994) 757-763
41. Nair P., and Mayberry J.F. Vegetarianism, dietary fibre and gastrointestinal disease. Dig Dis 12 (1994) 177-182
42. Korzenik J.R. Case closed? Diverticulitis: epidemiology and fiber. J Clin Gastroenterol 40 (2006) S112-S116
43. Painter N.S., and Burkitt D.P. Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 4 (1975) 3-12
44. Fisher N., Berry C.S., Fearn T., et al. Cereal dietary fiber consumption and diverticular disease: a lifespan study in rats. Am J Clin Nutr 42 (1985) 788-804
45. Patiner N.S., Almeida A.Z., and Colebourn K.W. Unprocessed bran in treatment of diverticular disease of colon. Br Med J 2 (1972) 137-140
46. Findlay J.M., Smith A.N., Mitchell W.D., et al. Effects of unprocessed bran on colon function in normal subjects and in diverticular disease. Lancet 1 (1974) 146-149
47. Taylor I., and Duthie H.L. Bran tablets and diverticular disease. Br Med J 1 (1976) 988-990
48. Brodribb A.J.M. Treatment of symptomatic diverticular disease with high-fibre diet. Lancet 2 (1997) 664-666
49. Fric P., and Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 15 (2003) 313-315
50. Tursi A., Brandimarte G., Elisei W., et al. Mesalamine and/or Lactobacillus casei for maintaining remission of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized study. Dig Liver Dis 37 (2005) S20-S26
51. Olesen M., and Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr 72 6 (2000) 1570-1575
52. Hunter J.O., Tuffnell Q., and Lee A.J. Controlled trial of oligofructose in the management of irritable bowel syndrome. J Nutr 129 7 Suppl (1999) 1451S-1453S
53. O'Mahony L., McCarthy J., Kelly P., et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128 3 (2005) 541-551
54. Whorwell P.J., Altringer L., Morel J., et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101 7 (2006) 1581-1590
55. Nobaek S., Johansson M.L., Molin G., et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95 5 (2000) 1231-1238
56. Niedzielin K., Kordecki H., and Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13 10 (2001) 1143-1147
57. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 38 6 Suppl (2004) S104-S106
58. Kim H.J., Camilleri M., McKinzie S., et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17 7 (2003) 895-904
59. O'Sullivan M.A., and O'Morain C.A. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 32 4 (2000) 294-301
60. Jailwala J., Imperiale T.F., and Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review. Ann Intern Med 133 2 (2000) 136-147
61. Floch M.H., and Narayan R. Diet in the irritable bowel syndrome. J Clin Gastroenterol 35 Suppl (2002) S45-S52
62. Floch M.H. Netter's gastroenterology (2005), Elsevier, Philadelphia
63. Cummings J.H., Southgate D.A.T., Branch W., et al. Colonic response to dietary fibre from carrot, cabbage, apple, bran and guar gum. Lancet 1 (1978) 5-9
64. Spiller G.A. Dietary fiber in human nutrition. 2nd edition (1993), CRC Press, Inc., Boca Raton (FL)
65. Muir J.G., Yeow E.G.S., Keogh J., et al. Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone. Am J Clin Nutr 79 (2004) 1020-1028
66. Malchow H.A. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?. J Clin Gastroenterol 25 4 (1997) 653-658
67. Guslandi M., Messi G., Sorghi M., et al. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 45 (2000) 1462-1464
68. Plein K., and Hotz J. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea-a pilot study. Z Gastroenterol 31 (1993) 129-134
69. Bousvaros A., Guandalini S., Baldassano R., et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 11 9 (2005) 833-839
70. Campieri M., Rizzello F., Venturi A., et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study versus mesalamine. Gastroenterology 118 (2000) A781
71. Prantera C., Scribano M.L., Falasco G., et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease. A randomized controlled trial with Lactobacillus GG. Gut 51 (2002) 405-409
72. Marteau P., Lemann M., Seksik P., et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 55 6 (2006) 842-847 Epub 2005 Dec 23
73. Gupta P., Andrew H., Kirschner B.S., et al. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 31 4 (2000) 453-457
74. McCarthy J., O'Mahony L., Dunne C., et al. An open trial of a novel probiotic as an alternative to steroids in mild/moderately active Crohn's disease. Gut 49 Suppl 3 (2001) A2447
75. Kanauchi O., Mitsuyama K., Araki Y., et al. Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr Pharm Des 9 (2003) 333-346
76. Kanauchi O., Mitsuyama K., Homma T., et al. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. Int J Mol Med 12 5 (2003) 701-704
77. Venturi A., Gionchetti P., Rizzello F., et al. Impact on the composition of the fecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmcol Ther 13 (1999) 1103-1108
78. Kruis W., Schutz E., Fric P., et al. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmcol Ther 11 (1997) 853-858
79. Rembacken B.J., Snelling A.M., Hawkey P.M., et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet 354 (1999) 635-639
80. Faubion W.A., and Sandborn W.J. Probiotic therapy with E. coli for ulcerative colitis: take the good with the bad. Gastroenterology 118 (2000) 630-631
81. Kruis W., Fric P., Pokrotnieks J., et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle1917 is as effective as with standard mesalazine. Gut 53 11 (2004) 1617-1623
82. Zocco M.A., Dal Verme L.Z., Cremonini F., et al. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 23 11 (2006) 1567-1574
83. Borody T.J., Warren E.F., Leis S.L., et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 37 1 (2003) 42-47
84. Guslandi M., Patrizia G., and Testoni P.A. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 15 (2003) 697-698
85. Tursi A., Brandimarte G., Giorgetti G.M., et al. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 10 11 (2004) PI126-PI131 Epub 2004 Oct 26
86. Bibiloni R., Fedorak R.N., Tannock G.W., et al. VSL #3 probiotic mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100 (2005) 1539-1546
87. Kato K., Mizuno S., Umesaki Y., et al. Randomized placebo-controlled trial assessing the effect of Bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 20 (2004) 1133-1141
88. Harig J.M., Soegel K.H., Komorowski R.A., et al. Treatment of diversion colitis with short-chain fatty acid irrigation. N Engl J Med 320 (1989) 23-27
89. Roediger W.E.W., and Nance S. Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp Pathol 67 (1986) 773-782
90. Scheppach W., Sommer H., Kirchner T., et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103 (1992) 51-56
91. Breuer R.I., Soergel K.H., Lashner B.A., et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomized, placebo controlled trial. Gut 40 (1997) 485-491
92. Lohmuller J.L., Pemberton J.H., Dozois R.R., et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 211 5 (1990) 622-627
93. Stahlberg D., Gullberg K., Liljeqvist L., et al. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 39 (1996) 1012-1018
94. Gionchetti P., Rizzello F., Venturi A., et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119 2 (2000) 305-309
95. Mimura T., Rizzello F., Helwig U., et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53 1 (2004) 108-114
96. Gionchetti P., Rizzello F., Helwig U., et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124 5 (2003) 1202-1209
97. Shen B., Brzezinski A., Fazio V.W., et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 22 8 (2005) 721-728
98. Floch M.H., Madsen K.K., Jenkins D.J.A., et al. Recommendations for probiotic use. J Clin Gastroenterol 40 (2006) 275-278
99. Kelly C.P., and Lamont J.T. Antibiotic-associated diarrhea, pseudomembranous colitis and Colostrium difficile-associated diarrhea and colitis. In: Feldman M., Friedman L.S., and Brandt L.J. (Eds). Gastrointestinal and liver disease. 8th edition (2006), Saunders, Philadelphia 2398-2412
100. Aas J., Gessert C.E., and Bakken J.S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tub. Clinical Infectious Diseases 36 (2003) 580-585
101. Persky S.E., and Brandt L.J. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 96 (2000) 3283-3285
102. Surawicz C.M., Elmer G.W., Speelman P., et al. Prevention of antibiotic associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96 (1989) 981-988
103. Dendukuri N., Costa V., McGregor M., et al. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 173 2 (2005) 167-170
104. McFarland L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101 (2006) 812-822
105. Lewis S., Burmeister S., and Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized controlled study. Clin Gastroenterol Hepatol 3 (2005) 442-448
106. Fitz G. Hepatic encephalopathy, hepatopulmonary syndromes, hepatorenal syndrome, and other complications of liver disease. In: Feldman M., Friedman L.S., and Brandt L.J. (Eds). Gastrointestinal and liver disease. 8th edition (2006), Saunders, Philadelphia 1965-1991
107. Elkington S.G., Floch M.H., and Conn H.O. Lactulose in the treatment of chronic portal-systemic encephalopathy. N Engl J Med 281 (1969) 408-411
108. Ballongue J., Schumann C., and Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 32 222 (1997) 41-44